Background
Unlike classical oncogenic retroviruses, the genomes of HIV-1, HIV-2 and SIV contain several additional genes besides those encoding Gag, Pol and Env polyprotein precursors [1] . Protein products of these additional genes play important roles in different stages of the viral life cycle [1, 2] . One of these is a myristoylated 27 kDa membraneassociated protein called Nef [3, 4] . Despite earlier controversies [5] [6] [7] [8] [9] [10] [11] , it has become clear that Nef plays an important role in viral pathogenesis. In the simian model of acquired immune deficiency syndrome (AIDS), the nef gene is essential for high levels of viremia and progression to AIDS [12] . Additionally, viruses from infected human long-term non-progressors (who do not manifest the symptoms of AIDS) often contain deletions in the conserved region of the nef gene [13, 14] . However, the molecular basis for this Nef phenotype remains poorly understood.
Previously, we and others demonstrated that Nef coimmunoprecipitates with two phosphoproteins, p62 and p72, known as Nef-associated kinase (NAK) activity [15] [16] [17] . Recently, it was suggested that NAK shares epitopes with p21-activated kinases (PAKs) [17] . In that study, antibodies against the amino-terminal 20 amino acids and the carboxy-terminal 19 amino acids of rat PAK1 -anti-PAK(N20) and anti-PAK(C19), respectively -could re-immunoprecipitate a phosphoprotein of 65 kDa that had previously been co-immunoprecipitated with epitopetagged Nef protein, and that had the same mobility as their immunoprecipitated NAK [17] . Moreover, the substrate specificity of this NAK was similar to that of PAK. However, no direct association between Nef and a known PAK could be demonstrated, and no signalling or functional correlates with viral replication were presented [17] .
In this study, we found that p62 and p72 are also recognized by some anti-PAK antibodies, that Nef not only associates with but also activates NAK, that this activation occurs via the small GTPases CDC42 and Rac1, and that this process activates the serum-response pathway. Moreover, dominant-negative forms of PAK (PAKR) and GTPases (CDC42Hs-N17 and Rac1-N17) decreased the levels of viral production in cells to those observed with virus from which the nef gene was deleted. Thus, the GTPases CDC42 and Rac1 play pivotal roles in effects of Nef in infected cells.
Results

Nef activates NAK, which bears structural similarity to PAK, in cells
To determine whether p62 and p72, like p65 [17] , are recognized by anti-PAK antibodies, we performed the experiments presented in Figure 1 . The p62 and p72 proteins are found in complexes that are immunoprecipitated by anti-Nef antibodies from T cells and are phosphorylated on serine residues in an in vitro kinase assay [15, 16] . In our hands, anti-PAK(N20), but not anti-PAK(C19), antibodies could recognize NAK in complexes obtained from Jurkat cells that stably expressed the CD8-Nef fusion protein; phosphorylation of NAK was detected by performing an in vitro kinase assay on the immunoprecipitates (Fig. 1a, lanes 2,4; Fig. 1b, lanes 2,4) . Although human PAK65 (hPAK65) itself was not activated by Nef in these cells (Fig. 1c, lane 2) , anti-PAK(C19) could recognize a constitutively active form of hPAK65 expressed in Jurkat cells (PAKE; Fig. 1c , lane 3 and Fig. 1d ). However, if we first disrupted the anti-Nef immunoprecipitates and then added the anti-PAK(C19) antibody, then NAK was also recognized by this antibody, in agreement with published results (data not shown) [17] . These results confirm that NAK bears structural similarity to PAK, suggest that epitopes in the carboxy-terminal part of NAK are not accessible to antibodies when NAK is in the Nef complex, and reveal that Nef not only binds to but also activates NAK. That NAK is not a known PAK was also confirmed by transient expression assays in COS cells and by in vitro transcription and translation experiments, which failed to demonstrate a direct association between Nef and known isoforms of PAK (PAK1, PAK2 and PAK3) (data not shown) [18] [19] [20] . Additionally, patterns of tryptic peptides obtained from PAKE and p62 (Fig. 1) were not identical (data not shown) [17] . The same results were obtained with cells infected with HIV-1.
Sequences in the amino and carboxyl termini are conserved among known PAKs [18] [19] [20] . The amino-terminal half of PAK (residues 1-249) is its regulatory domain, which binds to CDC42 and Rac1 via its GTPase-binding domain (residues 72-89) (Fig. 1d) . Because the carboxyterminal kinase domain (residues 250-525) is even more conserved among known PAKs, it is somewhat surprising that anti-PAK(C19) did not recognize NAK, and that the reactivity of anti-PAK(C19) appeared to be less than that [18, 19] . The GTPase-binding domain (GBD) is located between residues 72 and 89 [18, 19] . The amino-terminal 20 amino acids and the carboxy-terminal 19 amino acids, which are recognized by anti-PAK(N20) and anti-PAK(C19) antisera, respectively, are depicted by lines below hPAK65 [17] . hPAKE is a constitutively active PAK65, in which the threonine residue at position 403 is mutated to a glutamic acid (T403E). PAKR is a dominantnegative form of hPAK65 and contains the amino-terminal 225 amino acids of hPAK65 [35] . PAKR-LL is identical to PAKR, except that the two histidine residues at positions 84 and 87 are substituted by leucines (H84L, H87L), which decreases its interactions with the small GTPases. A n t i -N e f A n t i -P A K ( N 2 0 )
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The activation of NAK by Nef occurs via CDC42 and Rac1
Because NAK is antigenically related to PAK, we next tested the ability of PAKR ( Fig. 1d ; [18] ), to block the activation of NAK by Nef. CD8-Nef and PAKR proteins, which were co-expressed in Jurkat cells, were immunoprecipitated with the anti-CD8 antibody and subjected to in vitro kinase assays. As seen in Figure 2a (lane 2, top panel), PAKR prevented the co-immunoprecipitation of active p62 and p72 with Nef. This result was confirmed in COS cells, where interactions between Nef and p62 were also blocked by PAKR in a dose-dependent manner (Fig. 2b , top panel, lanes 4-6). Note that, in contrast to Jurkat cells, only p62 was seen in COS cells, as described previously [15, 16] . Thus, it is possible that p72 is a lymphocyte-specific substrate for NAK. Because the levels of the CD8-Nef fusion protein were not affected ( Fig. 2a,b , bottom panels), and the control luciferase activity expressed from the RSV LTR promotor was unchanged (data not shown), the inhibition of NAK was not a non-specific effect of PAKR. Moreover, PAKR-LL ( Fig. 1d ), which has a lower affinity for CDC42 and Rac1 (A. Abo, data not shown), did not inhibit the phosphorylation of p62 as efficiently as did PAKR (Fig. 2c , lanes 2,3). The same result was obtained using wild-type Nef from simian immunodeficiency virus (SIV; Fig. 2e ). These data suggest that CDC42 and Rac1 are involved in Nef's association with and activation of NAK.
To investigate this role of CDC42 and Rac1 directly, we coexpressed CD8-Nef with constitutively active and dominant-negative CDC42 (CDC42Hs-V12 and CDC42-N17, respectively) and/or Rac1 (Rac1-V12 and Rac1-N17, respectively) in COS cells. Indeed, CDC42Hs-N17, Rac1-N17 or both blocked the activity of NAK (Fig. 3a , lanes 4-12). In sharp contrast, CDC42Hs-V12 and Rac1-V12 increased the activity of NAK in the presence of Nef (Fig. 3b , lanes 2,3) and they overcame the inhibition of NAK by PAKR (Fig.  3b, lanes 6,8) . In parallel experiments, constitutively active and dominant-negative forms of RhoA (RhoA-V14 and RhoA-N19, respectively) had no effect on NAK (data not shown). Thus CDC42 and/or Rac1, but not RhoA, are required for Nef to associate with and activate NAK. To confirm that small GTPases are required to activate NAK, we transiently expressed Nef in parental Rat1 fibroblasts and in Rat1 cells stably expressing CDC42Hs-V12 (Rat1/CDC42Hs-V12 cells). As seen in Figure 3c , the activity of NAK was more than 20 times higher in Rat1/CDC42Hs-V12 cells than in parental Rat1 cells (compare lanes 4 and 6). Thus, the activity of the small GTPases is limiting and, when CDC42Hs-V12 is expressed, Nef is able to associate with more NAK, or NAK is more active in the Nef complex. Finally, the individual components of the NAK complex could be assembled in vitro (Fig. 3d) . Recombinant Nef and CDC42Hs were incubated with GTP␥S and lysates from Jurkat cells for the complete reconstitution of NAK activity in a cell-free system (Fig. 3d, lanes 3,4) . This activation was GTP-dependent, as substitution of GTP␥S with GDP␥S resulted in the loss of phosphorylation of p62 (data not shown). Because recombinant hPAK65 did not substitute for lysates from Jurkat cells (data not shown), these lysates most probably provided the serine kinase and its protein substrates. We conclude that Nef associates with and activates NAK via CDC42 and Rac1.
Nef activates the serum-response pathway via CDC42 and Rac1 in cells
Small GTPases, including CDC42 and Rac1, are also involved in the activation of the serum-response pathway [21, 22] . To determine if proteins that interact with the serum-response element (SRE) are the downstream effectors of NAK, we co-expressed Nef with a plasmid target that contained five SREs 5′ of the TATA box and the firefly luciferase reporter gene in NIH 3T3 cells. The level of luciferase activity in these cells was five-fold higher in the presence of Nef (Fig. 4a, bars 3,4) . Moreover, the mutant Nef, in which two arginine residues at positions 109 and 110 were substituted by leucines, and which no longer associates with and activates NAK [16] , failed to activate the serum-response pathway (bar 5). The activation via SREs was blocked by PAKR (Fig. 4a, bar 6 ) as well as by CDC42Hs-N17 and Rac1-N17 (bar 7); thus, the situation was similar to that seen with NAK. As expected, the activation by serum was also inhibited by PAKR (Fig. 4a, bars 9,10 ). At present, we do not know if the serum-response factor (SRF) or ELK-1, both of which are required for the binding to and activation of the SRE [21, 22] , are the targets of this activation. We conclude that the activation of the serum-response pathway by Nef also depends on CDC42, Rac1 and NAK.
Dominant-negative forms of PAK and GTPases block viral production in cells
To determine whether CDC42 and Rac1 might be responsible for the increased levels of viral replication in the presence of Nef, we studied the contributions of these small GTPases on the replication of HIV-1 by measuring the levels of the p24Gag antigen in the cell culture supernatants. The HIV-1 (BRU3 strain) proviral DNA was introduced alone or with a plasmid encoding PAKR into COS cells [23, 24] ; an isogenic provirus lacking the nef gene was used as the control. We consistently found that the levels of p24Gag were between four-and five-fold lower with the nef-deleted virus (Fig. 4b , compare bars 1 and 5). Because this phenotype was rescued by co-expressing Nef from a separate plasmid (Fig. 4b, bar 6 ), this decreased synthesis of HIV-1 was due to the absence of the nef gene. Moreover, when the wild-type provirus was co-expressed with PAKR, the levels of p24Gag were reduced to those observed with the nef-deleted provirus (Fig. 4b, bar 2) . The co-expression of CDC42Hs-N17 and Rac1-N17 resulted in a similar decrease in the level of HIV-1 production (Fig. 4b, bar 3) . Moreover, in cells that stably expressed PAKR, we detected little to no viral replication (data not shown).
Neither PAKR nor CDC42Hs-N17 and Rac1-N17 had any effect on the nef-deleted virus (data not shown). Thus, CDC42 and Rac1 are required for optimal levels of Nefdependent viral replication in vivo.
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Discussion
Our data confirm that NAK is immunologically and functionally related to PAK [17] . In addition, they show that Nef activates NAK via CDC42 and Rac1, resulting in the activation of downstream cellular effector functions. Furthermore, the inhibition of the viral production by PAKR and dominant-negative CDC42 or Rac1 indicates that NAK is required for optimal levels of viral replication in vivo.
On the basis of our results, NAK could be a new isoform of PAK. Although NAK, like PAK, is also under the control of CDC42 and Rac1, Nef and known isoforms of PAK do not associate in cells. Moreover, in sharp contrast to constitutively active CDC42 and Rac1 proteins, neither constitutively active hPAK1 (hPAK L107F ) nor hPAK65 (PAKE) proteins restored the activity of NAK blocked by PAKR. Finally, two-dimensional tryptic peptide maps of p62 and PAKE were different (data not shown).
The significance of the activation of the serum-response pathway by Nef is not clear. However, it is possible that this activation changes the milieu of the infected cell leading to higher levels of viral production. In this regard, it is interesting to note that Nef from SIV isolate pbj14 transforms and leads to the serum-independent growth of 3T3 cells [25] . Our results suggest that HIV-1 Nef has similar, albeit weaker effects in the same cells.
Our viral production assay measures de novo synthesis and/or release of viral particles in transfected cells. It does not include the steps of reverse transcription and integration that are thought to be the target of Nef in the viral infectivity assay described by Miller et al. [26] . However, our preliminary results failed to detect any involvement of Rac1 and CDC42 in the viral infectivity assays in CD4-expressing HeLa cells (data not shown). This discrepancy could result from an inability to package these small GTPases into the virion. We conclude that the augmentation of viral production adds another layer of complexity to the function of Nef in the viral life cycle.
How does Nef activate NAK? One possibility is that Nef activates an upstream effector of both small GTPases and/or stimulates an exchange factor (Fig. 5) . A good example of a protein that might be activated by Nef is the human oncogene Dbl, which is an exchange factor for CDC42 [27] . Alternatively, Nef could trap an active form of NAK that is activated constitutively by CDC42 and Rac1. At present, we cannot distinguish between these possibilities. However, differences between these pathways might be important for other downstream effector functions, such as the effects of CDC42 on the cytoskeleton, and of Rac1 on endocytosis (Fig. 5) ; see below.
The Rho family GTPases, including CDC42 and Rac1, play major roles in the cytoskeletal rearrangement in response to a variety of stimuli in organisms as diverse as yeast and mammals [28, 29] . In yeast, CDC42 and its downstream effector Ste20, which is equivalent to PAK in humans, play a central role in the response to mating pheromones and budding [30] [31] [32] . In Drosophila, CDC42 and Rac1 and their direct effector DPAK have been implicated in the dorsal closure, a developmental process that requires actin assembly and disassembly [33] . In mammals, these small GTPases are involved in the formation of filopodia, lamellipodia and membrane ruffling [34] . Moreover, several effectors for the mammalian CDC42 and Rac1 have been identified. The best studied examples include human PAKs, rat PAKs and WASP (WiscottAldrich syndrome protein). WASP is important for the polymerization of actin and for T-cell activation [29] , whereas PAKs play a critical role in the activation of the JNK pathway [35] . Recent studies have suggested an additional role for CDC42 and Rac1 in the endocytosis of certain receptors in mammalian cells [36] .
All these effectors could be potential targets of Nef. By activating small GTPases, Nef could facilitate the viral 1682 Current Biology 1996, Vol 6 No 12
Figure 5
Model for the role of CDC42 and Rac1 in the activation of NAK and HIV-1 replication. Interactions between Nef and NAK are essential for viral replication. Furthermore, Nef's association with and activation of NAK is dependent on the activation of GTPases CDC42 and Rac1. It is possible that Nef stimulates a GTP/GDP exchange factor to activate CDC42 and Rac1 (indicated by the question mark). Alternatively CDC42 and Rac1 may play a role in the activation of NAK by inducing the association between NAK and Nef. Activation of NAK by Nef may lead to higher viral replication through the SRE pathway. Finally, CDC42 can activate the Wiscott-Aldrich syndrome protein (WASP), which leads to the rearrangement in the actin cytoskeleton [29] . These latter effects might also promote the budding of virions from the infected cells. budding process, or the endocytosis of surface proteins such as CD4; or it could affect virion morphology and composition by phosphorylating viral structural proteins, such as the matrix protein [37] . This study of Nef and small GTPases has elucidated a novel aspect of viral replication. In the host, interfering with this signalling cascade should decrease levels of viremia and might contribute to the treatment of AIDS. With the cloning and further characterization of NAK, a unified and comprehensive model that could explain many phenotypes of Nef may be on the horizon.
Materials and methods
Tissue culture and in vitro kinase assays
Cells that express the wild-type Nef or CD8-Nef fusion proteins were lysed and their proteins immunoprecipitated with anti-Nef, anti-PAK(N20), anti-CD8 or anti-PAK(C19) antibodies. Stable cell lines were maintained, and immunoprecipitations and in vitro kinase assays were performed as described previously [15, 16, 38] . Transient expression assays were performed using lipofectamine (GIBCO/BRL, Gaithersburg, Maryland) and cells were harvested 48 h after transfections. COS cells expressed from 2 g of plasmid encoding CD8-Nef (pCN; Figs 2 and 3), increasing amounts (0.1 1, and 2 g) of plasmids encoding PAKR, CDC42Hs-N17 or Rac1-N17, and 2 g of PAKR-LL. Rat1/CDC42Hs-V12 cells were created by transfecting Rat1 cells with pCVN expression vectors, which direct the synthesis of CDC42Hs-V12, and selecting them with 400 g ml -1 of G418. pCT (encoding CD8) and pCN (encoding CD8-Nef) [38] were then transfected into the cells. The transfected cells expressing either combination of proteins were analyzed. For western blotting, proteins were transferred from SDS-PAGE gels onto Immobilon membranes and probed with the anti-Nef antibody, as described previously [38] .
In vitro reconstitution experiments
The cDNA encoding HIV-1 Nef, which contains the Glu-Glu epitope at the amino terminus, was cloned into a baculovirus expression system, as described previously [18] . Recombinant Nef (5 g) and CDC42Hs (5 g), which was preloaded with GTP␥S, and lysates from Jurkat cells (5 × 10 5 cell equivalents) were incubated for 2 h. Other combinations are described in the legend to Figure 3d . Nef was immunoprecipitated with the anti-Glu-Glu monoclonal antibody and subjected to the in vitro kinase assay [15, 16] . To remove any phosphorylated proteins, which might be associated with Nef, the recombinant Nef was treated with -phosphatase (PPT 2,3,4,5; New England BioLabs, Cambridge, Massachusetts) for 30 min according to manufacturer's instructions. Twice the amount of lysate was included in Fig. 3d , lanes 3 and 5.
Serum-response assay
NIH 3T3 cells were maintained in DMEM medium containing 10 % fetal calf serum (FCS). Before transfections, the cells were starved for 6 h in serum-free media. Cells were then transfected with 0.5 and 4 g of plasmid targets and effectors, respectively, using lipofectamine (GIBCO/BRL, Gaithersburg, Maryland). Transfected cells were maintained in the serum-free medium for 24 h, lysed, and luciferase assays were performed. For the serum control, 15 % FCS was added to the medium after transfection. Values represent the average of three independent transfections performed in parallel, where the standard error of the mean was less than 15 %. 5XSRE luciferase was a generous gift from S. An. This fragment, which contained five copies of the SRE from the c-fos promoter, the E1b TATA box and the firefly luciferase gene, was cloned into pGL-3 (Promega Biotech, Madison, Wisconsin).
HIV-1 production assays
COS cells were transfected with indicated plasmids using lipofectamine (GIBCO/BRL), as above. 48 h later, supernatants from transfected cells were filtered using 0.45 m Acrodiscs (Gelman Sciences, Ann Arbor, Missouri) and serial dilutions were assayed for levels of p24Gag by ELISA (Coulter, Hialeah, Florida). The concentrations (in pg ml -1 ) were calculated using an internal standard provided with the kit. Both the HIV-1 provirus and the HIV-1 provirus with a deletion in the nef gene (between nucleotides 8390 and 8661, a region between the env gene and 3′ LTR with no other known function) were kindly provided by K. Peden and M. Emerman.
